French invoke Safeguard clause for condoms
This article was originally published in Clinica
Condoms may only be marketed in France if they are subject to batch control by a Notified Body under the Medical Devices Directive, according to French condom standard NF S 97-031. In publishing its decree, the French government is the first to make use of the Medical Devices Directive's Safeguard clause - on the grounds of inadequate standards. The European Commission is currently reviewing the situation.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.